Covid-19 Impact on RSV Diagnostics Market, Global Research Reports 2020-2021
This report covers market size and forecasts of RSV Diagnostics, including the following market information:
Major competitors identified in this market include bioM?rieux, Abbott, Roche, BD, Thermo Fisher, Luminex, Danaher, Biocartis, Hologic, etc.
Based on the Region:
- Global RSV Diagnostics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global RSV Diagnostics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global RSV Diagnostics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global RSV Diagnostics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include bioM?rieux, Abbott, Roche, BD, Thermo Fisher, Luminex, Danaher, Biocartis, Hologic, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Kits and Assays
- Instruments
- Other
- Hospitals & Clinics
- Clinical Laboratories
- Homecare
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on RSV Diagnostics Industry
1.7 COVID-19 Impact: RSV Diagnostics Market Trends
2 GLOBAL RSV DIAGNOSTICS QUARTERLY MARKET SIZE ANALYSIS
2.1 RSV Diagnostics Business Impact Assessment - COVID-19
2.1.1 Global RSV Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global RSV Diagnostics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global RSV Diagnostics Quarterly Market Size, 2019 VS 2020
3.2 By Players, RSV Diagnostics Headquarters and Area Served
3.3 Date of Key Players Enter into RSV Diagnostics Market
3.4 Key Players RSV Diagnostics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON RSV DIAGNOSTICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Kits and Assays
1.4.2 Instruments
1.4.3 Other
4.2 By Type, Global RSV Diagnostics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON RSV DIAGNOSTICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospitals & Clinics
5.5.2 Clinical Laboratories
5.5.3 Homecare
5.2 By Application, Global RSV Diagnostics Market Size, 2019-2021
5.2.1 By Application, Global RSV Diagnostics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 bioM?rieux
7.1.1 bioM?rieux Business Overview
7.1.2 bioM?rieux RSV Diagnostics Quarterly Revenue, 2020
7.1.3 bioM?rieux RSV Diagnostics Product Introduction
7.1.4 bioM?rieux Response to COVID-19 and Related Developments
7.2 Abbott
7.2.1 Abbott Business Overview
7.2.2 Abbott RSV Diagnostics Quarterly Revenue, 2020
7.2.3 Abbott RSV Diagnostics Product Introduction
7.2.4 Abbott Response to COVID-19 and Related Developments
7.3 Roche
7.3.1 Roche Business Overview
7.3.2 Roche RSV Diagnostics Quarterly Revenue, 2020
7.3.3 Roche RSV Diagnostics Product Introduction
7.3.4 Roche Response to COVID-19 and Related Developments
7.4 BD
7.4.1 BD Business Overview
7.4.2 BD RSV Diagnostics Quarterly Revenue, 2020
7.4.3 BD RSV Diagnostics Product Introduction
7.4.4 BD Response to COVID-19 and Related Developments
7.5 Thermo Fisher
7.5.1 Thermo Fisher Business Overview
7.5.2 Thermo Fisher RSV Diagnostics Quarterly Revenue, 2020
7.5.3 Thermo Fisher RSV Diagnostics Product Introduction
7.5.4 Thermo Fisher Response to COVID-19 and Related Developments
7.6 Luminex
7.6.1 Luminex Business Overview
7.6.2 Luminex RSV Diagnostics Quarterly Revenue, 2020
7.6.3 Luminex RSV Diagnostics Product Introduction
7.6.4 Luminex Response to COVID-19 and Related Developments
7.7 Danaher
7.7.1 Danaher Business Overview
7.7.2 Danaher RSV Diagnostics Quarterly Revenue, 2020
7.7.3 Danaher RSV Diagnostics Product Introduction
7.7.4 Danaher Response to COVID-19 and Related Developments
7.8 Biocartis
7.8.1 Biocartis Business Overview
7.8.2 Biocartis RSV Diagnostics Quarterly Revenue, 2020
7.8.3 Biocartis RSV Diagnostics Product Introduction
7.8.4 Biocartis Response to COVID-19 and Related Developments
7.9 Hologic
7.9.1 Hologic Business Overview
7.9.2 Hologic RSV Diagnostics Quarterly Revenue, 2020
7.9.3 Hologic RSV Diagnostics Product Introduction
7.9.4 Hologic Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on RSV Diagnostics Industry
1.7 COVID-19 Impact: RSV Diagnostics Market Trends
2 GLOBAL RSV DIAGNOSTICS QUARTERLY MARKET SIZE ANALYSIS
2.1 RSV Diagnostics Business Impact Assessment - COVID-19
2.1.1 Global RSV Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global RSV Diagnostics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global RSV Diagnostics Quarterly Market Size, 2019 VS 2020
3.2 By Players, RSV Diagnostics Headquarters and Area Served
3.3 Date of Key Players Enter into RSV Diagnostics Market
3.4 Key Players RSV Diagnostics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON RSV DIAGNOSTICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Kits and Assays
1.4.2 Instruments
1.4.3 Other
4.2 By Type, Global RSV Diagnostics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON RSV DIAGNOSTICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospitals & Clinics
5.5.2 Clinical Laboratories
5.5.3 Homecare
5.2 By Application, Global RSV Diagnostics Market Size, 2019-2021
5.2.1 By Application, Global RSV Diagnostics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 bioM?rieux
7.1.1 bioM?rieux Business Overview
7.1.2 bioM?rieux RSV Diagnostics Quarterly Revenue, 2020
7.1.3 bioM?rieux RSV Diagnostics Product Introduction
7.1.4 bioM?rieux Response to COVID-19 and Related Developments
7.2 Abbott
7.2.1 Abbott Business Overview
7.2.2 Abbott RSV Diagnostics Quarterly Revenue, 2020
7.2.3 Abbott RSV Diagnostics Product Introduction
7.2.4 Abbott Response to COVID-19 and Related Developments
7.3 Roche
7.3.1 Roche Business Overview
7.3.2 Roche RSV Diagnostics Quarterly Revenue, 2020
7.3.3 Roche RSV Diagnostics Product Introduction
7.3.4 Roche Response to COVID-19 and Related Developments
7.4 BD
7.4.1 BD Business Overview
7.4.2 BD RSV Diagnostics Quarterly Revenue, 2020
7.4.3 BD RSV Diagnostics Product Introduction
7.4.4 BD Response to COVID-19 and Related Developments
7.5 Thermo Fisher
7.5.1 Thermo Fisher Business Overview
7.5.2 Thermo Fisher RSV Diagnostics Quarterly Revenue, 2020
7.5.3 Thermo Fisher RSV Diagnostics Product Introduction
7.5.4 Thermo Fisher Response to COVID-19 and Related Developments
7.6 Luminex
7.6.1 Luminex Business Overview
7.6.2 Luminex RSV Diagnostics Quarterly Revenue, 2020
7.6.3 Luminex RSV Diagnostics Product Introduction
7.6.4 Luminex Response to COVID-19 and Related Developments
7.7 Danaher
7.7.1 Danaher Business Overview
7.7.2 Danaher RSV Diagnostics Quarterly Revenue, 2020
7.7.3 Danaher RSV Diagnostics Product Introduction
7.7.4 Danaher Response to COVID-19 and Related Developments
7.8 Biocartis
7.8.1 Biocartis Business Overview
7.8.2 Biocartis RSV Diagnostics Quarterly Revenue, 2020
7.8.3 Biocartis RSV Diagnostics Product Introduction
7.8.4 Biocartis Response to COVID-19 and Related Developments
7.9 Hologic
7.9.1 Hologic Business Overview
7.9.2 Hologic RSV Diagnostics Quarterly Revenue, 2020
7.9.3 Hologic RSV Diagnostics Product Introduction
7.9.4 Hologic Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on RSV Diagnostics Assessment
Table 9. COVID-19 Impact: RSV Diagnostics Market Trends
Table 10. COVID-19 Impact Global RSV Diagnostics Market Size
Table 11. Global RSV Diagnostics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global RSV Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global RSV Diagnostics Market Growth Drivers
Table 14. Global RSV Diagnostics Market Restraints
Table 15. Global RSV Diagnostics Market Opportunities
Table 16. Global RSV Diagnostics Market Challenges
Table 17. By Players, RSV Diagnostics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, RSV Diagnostics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key RSV Diagnostics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into RSV Diagnostics Market
Table 21. Key Players RSV Diagnostics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global RSV Diagnostics Market Size 2019-2021, (US$ Million)
Table 24. Global RSV Diagnostics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global RSV Diagnostics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 57. bioM?rieux Business Overview
Table 58. bioM?rieux RSV Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. bioM?rieux RSV Diagnostics Product
Table 60. bioM?rieux Response to COVID-19 and Related Developments
Table 61. Abbott Business Overview
Table 62. Abbott RSV Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Abbott RSV Diagnostics Product
Table 64. Abbott Response to COVID-19 and Related Developments
Table 65. Roche Business Overview
Table 66. Roche RSV Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Roche RSV Diagnostics Product
Table 68. Roche Response to COVID-19 and Related Developments
Table 69. BD Business Overview
Table 70. BD RSV Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. BD RSV Diagnostics Product
Table 72. BD Response to COVID-19 and Related Developments
Table 73. Thermo Fisher Business Overview
Table 74. Thermo Fisher RSV Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Thermo Fisher RSV Diagnostics Product
Table 76. Thermo Fisher Response to COVID-19 and Related Developments
Table 77. Luminex Business Overview
Table 78. Luminex RSV Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Luminex RSV Diagnostics Product
Table 80. Luminex Response to COVID-19 and Related Developments
Table 81. Danaher Business Overview
Table 82. Danaher RSV Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Danaher RSV Diagnostics Product
Table 84. Danaher Response to COVID-19 and Related Developments
Table 85. Biocartis Business Overview
Table 86. Biocartis RSV Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Biocartis RSV Diagnostics Product
Table 88. Biocartis Response to COVID-19 and Related Developments
Table 89. Hologic Business Overview
Table 90. Hologic RSV Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Hologic RSV Diagnostics Product
Table 92. Hologic Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on RSV Diagnostics Assessment
Table 9. COVID-19 Impact: RSV Diagnostics Market Trends
Table 10. COVID-19 Impact Global RSV Diagnostics Market Size
Table 11. Global RSV Diagnostics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global RSV Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global RSV Diagnostics Market Growth Drivers
Table 14. Global RSV Diagnostics Market Restraints
Table 15. Global RSV Diagnostics Market Opportunities
Table 16. Global RSV Diagnostics Market Challenges
Table 17. By Players, RSV Diagnostics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, RSV Diagnostics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key RSV Diagnostics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into RSV Diagnostics Market
Table 21. Key Players RSV Diagnostics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global RSV Diagnostics Market Size 2019-2021, (US$ Million)
Table 24. Global RSV Diagnostics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global RSV Diagnostics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa RSV Diagnostics Market Size, 2019-2021 (US$ Million)
Table 57. bioM?rieux Business Overview
Table 58. bioM?rieux RSV Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. bioM?rieux RSV Diagnostics Product
Table 60. bioM?rieux Response to COVID-19 and Related Developments
Table 61. Abbott Business Overview
Table 62. Abbott RSV Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Abbott RSV Diagnostics Product
Table 64. Abbott Response to COVID-19 and Related Developments
Table 65. Roche Business Overview
Table 66. Roche RSV Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Roche RSV Diagnostics Product
Table 68. Roche Response to COVID-19 and Related Developments
Table 69. BD Business Overview
Table 70. BD RSV Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. BD RSV Diagnostics Product
Table 72. BD Response to COVID-19 and Related Developments
Table 73. Thermo Fisher Business Overview
Table 74. Thermo Fisher RSV Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Thermo Fisher RSV Diagnostics Product
Table 76. Thermo Fisher Response to COVID-19 and Related Developments
Table 77. Luminex Business Overview
Table 78. Luminex RSV Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Luminex RSV Diagnostics Product
Table 80. Luminex Response to COVID-19 and Related Developments
Table 81. Danaher Business Overview
Table 82. Danaher RSV Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Danaher RSV Diagnostics Product
Table 84. Danaher Response to COVID-19 and Related Developments
Table 85. Biocartis Business Overview
Table 86. Biocartis RSV Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Biocartis RSV Diagnostics Product
Table 88. Biocartis Response to COVID-19 and Related Developments
Table 89. Hologic Business Overview
Table 90. Hologic RSV Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Hologic RSV Diagnostics Product
Table 92. Hologic Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. RSV Diagnostics Product Picture
Figure 2. RSV Diagnostics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global RSV Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global RSV Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global RSV Diagnostics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global RSV Diagnostics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global RSV Diagnostics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global RSV Diagnostics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific RSV Diagnostics Market Size Market Share, 2019-2021
Figure 1. RSV Diagnostics Product Picture
Figure 2. RSV Diagnostics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global RSV Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global RSV Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global RSV Diagnostics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global RSV Diagnostics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global RSV Diagnostics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global RSV Diagnostics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific RSV Diagnostics Market Size Market Share, 2019-2021
